The proof-of-concept study is one of the first to combine B and T cell analysis and potentially paves the way for tests that ...

Unity Software's Q4 results show progress amid challenges. Learn about its AI ad tech, future growth prospects, and why 2025 ...

Unity Software (U) shares experienced a dramatic increase of over 30% after the game engine company reported fourth-quarter ...

If you want a CPU that has the floating point performance of a GPU, all you have to do is wait six or so years and the CPU ...

With the advertising business being rebooted, Unity's turnaround is starting to take shape. Much of Unity's sales decline was ...

The transition to Vector adds uncertainty in Grow ... While the balance sheet remains leveraged, its ability to sustain positive free cash flow despite operational struggles offers some stability.

Unity Software Inc (U) reports a strong Q4 2024 with revenue and adjusted EBITDA exceeding guidance, driven by robust growth in Create Solutions and a promising partnership with Google.

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis is being tested in human ...

Snap a picture of any product and learn everything about it. 3 Canadians said enough to unclear products labeling, they decided to help con ...

Trump has always been a wrecking ball, but now that he’s pummeling Big Tech’s perceived enemies, he’s become a hero to a ...

The cell and gene therapies in rare disorders market is expected to grow at a significantly high rate during the forecast period (2025–2034) and main ...

This valuable study reports on the critical role of ANKRD5 (ANKEF1) in sperm motility and male fertility. However, the supporting data remain incomplete. This work will be of interest to biomedical ...